Description
Introduction
This analysis examines the historical and forecast performance for Pfizer in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfol...(more)
Description
Introduction
If consolidation is so advantageous for boosting a pharma company to a new level of productivity, why has
Pfizer engaged in not just one but three mega-mergers in the past ...(more)
Description
On 26th January 2009, Pfizer announced plans to acquire Wyeth for $68 billion. Pfizer’s CEO, Jeffrey B Kindler, insisted the deal would be different from the company’s earlier mega-deals i...(more)
Description
"Looming patent expiry a major force in driving valuation"
Drugs with annual sales totalling over US$86 B in 2007 are due to go off patent by 2012. Therefore, the application of novel drug del...(more)